Good Money After Bad

Submitted by: Submitted by

Views: 410

Words: 1312

Pages: 6

Category: Business and Industry

Date Submitted: 03/07/2012 12:36 PM

Report This Essay

United States and its population, over 308 million habitants, is the 3rd largest country in the planet, when compared with countries such as China and India (data, 2010). According to an article called “The medical device market in the USA”, at an estimated US$105 Billion in 2011, the US Medical Device Market is the World’s largest. United States is home to various medical devices producers; American companies such as Johnson & Johnson, General Electric (GE), among others, are part of the top 10 medical devices manufacturers in the planet. (MPO, 2012). With that said, the Medical Devices industry is considered large and with excellent potential for growth, due to the high investments in research and development.

The global market for medical device products is full of competitors and their big companies are always looking to sponsor and obtain multiple and innovative ideas, to change and impact the quality of people’s lives, and with the sole objective of getting positive financial balances and revenue in convenient periods of time. It’s been said, that investing in ideas, such as medical devices, offered benefits of low Capital investment and high benefits with short time exiting, all of this, produced by the fact that they can easily enter the market, when comparing with new drugs; that is leading biomedical investors, to turn their investing interests to the medical devices industry. (FDA, 2010). According to the FDA, agency in charge of protecting the public health by regulating and establishing the effectiveness, safety and transparency of Health care product developments, and its viability to come out to the market, it’s been determined that they are now taking more time to make their decisions, when accepting or rejecting “prototype” submissions, for their review and approval, and clearly, not all medical devices pass and qualify their demanding review programs.

Since President Obama passed the Healthcare reform bill in 2010, when giving 30...